Management of Autoimmune Encephalitis

Autoimmune encephalitis presents a complex challenge in clinical practice. Epidemiologically, its incidence is rising, with various types and classifications based on antigen targets. Clinical manifestations range from cognitive impairment to seizures, necessitating prompt recognition and management. Acutely, immunotherapy comprising corticosteroids, IV immunoglobulins, or plasmapheresis aims to halt immune-mediated damage, followed by bridging with maintenance immunosuppression like rituximab....